BASED IN SAN DIEGO
A Biotech Solutions Company with Two Breakthrough Technologies
A proprietary bio-polymer that performs two vital functions better than existing alternatives to:
- Capture targeted biological material for pathogen diagnostics; and
- Deliver functional compounds that can speed up and dramatically improve healing
A suite of dynamic rejuvenating biological compounds, derived from pluripotent stem cells, that deliver growth factors and healing cytokines optimized for effectiveness and bioavailability
Our Three Markets
The only COVID-19 Solution That Monitors for Up To a Year
For this and future pathogen outbreaks.
A system of bandages with embedded stem cell cultured media to enhance the body's self-repair function for severe wounds
DIABETES TRANSPLANT INTERVENTION THERAPY
A diabetes transplant Intervention Therapy where we have the potential to create an implant that replaces the insulin production function for Type 1 Diabetes sufferers
There are Dozens of Covid Tests
But Only One
FOR COVID-19 AND BEYOND
The surprising speed and lethality of Covid- 19’s group spread has shown our vulnerability to novel pathogens . . . at any time . . . and every place people congregate.
Customer facing companies are searching for a comprehensive solution to monitor (up to 1 year) all personnel across all installations ranging from airport ticket counters to military bases to aircraft carriers.
The proprietary capability of Diomat™ allows it to bind and hold a recombinant Purified Protein Derivative (PPD) that indicates the presence of antigens (infection), enabling visualization to the naked eye for a wearable, clearly readable diagnostic monitor.
As levels of air support have become more stretched in recent years, it takes much longer for soldiers wounded in the battlefield to transit to medical support
With limited space and weight in pack soldiers need a lightweight all in one solution for immediate wound care that can deliver extended care with no need for redressing
Breakthrough wound rejuvenation system powered by pluripotent, ethically derived, human stem cells. Delivered by our proprietary Diomat™ bandage system
Diabetes Transplant Intervention Therapy
How Diomics Transforms Diabetes Treatment
34 million people in the United States — about 10% of the population lack insulin-producing cells, known as beta cells, from damage or depletion
Stem Cell Transplant Therapy has proven effective but temporary since the 1990’s because the patient’s antibodies attack and destroy the implanted beta cells
Our preliminary investigation of building a Diomat™ cage to protect embedded stem cells has yielded promising results in animal studies
An embedded Diomics Cell Islets cage holds the promise of eliminating the need for insulin injections for up to a year. Transforming Diabetics Lives Forever